FOCL
EDAP TMS S.A. American Depositary Shares
FOCL trails on the overall score without a compensating advantage in the available component scores.
LLY
Eli Lilly and Company
LLY has the edge over FOCL overall, supported by stronger fundamentals and lower modeled downside.
FOCL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Healthy |
FOCL's balance sheet is currently healthy, but its revenue, profitability and cash flow are under pressure.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
FOCL PE Valuation
FOCL has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
FOCL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect FOCL's losses to shrink, with revenue declining.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
LLY has the edge over FOCL on the outlook, with more favorable revenue expectations.
FOCL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.98 | -$0.39 |
| Q2 2024 | -$0.58 | -$0.07 |
| Q1 2024 | -$0.54 | -$0.23 |
| Q4 2023 | -$0.63 | -$0.55 |
| Q3 2023 | -$0.63 | -673% |
| Q2 2023 | -$0.51 | -738% |
| Q1 2023 | -$0.31 | -3200% |
| Q4 2022 | -$0.08 | -500% |
FOCL lost $0.98 per share over the past year, a bigger loss than the year before.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over FOCL on earnings quality, reporting a profit while its opponent remains loss making.
FOCL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.8M | -39% |
| Q2 2026 | $13.2M | -27% |
| Q1 2026 | $17.8M | +25% |
| Q4 2025 | $21.9M | +0.9% |
| Q2 2025 | $18.2M | +7% |
| Q1 2025 | $14.3M | -12% |
| Q4 2024 | $21.7M | +2.8% |
| Q2 2024 | $17M | +9.4% |
FOCL's revenue is shrinking: $10M last quarter, down 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -79% | -44 points |
| Q2 2026 | -61% | -25 points |
| Q1 2026 | -41% | +2.9 points |
| Q4 2025 | -28% | -9.1 points |
| Q3 2025 | -35% | N/A |
| Q2 2025 | -36% | +3 points |
| Q1 2025 | -44% | -12 points |
| Q4 2024 | -18% | -0.6 points |
FOCL's operating margin was −79% last quarter, down 44 points from the same quarter a year ago, near the bottom of its range since 2015.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over FOCL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over FOCL on profitability, with a higher operating margin.
FOCL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4M | +$891.5K |
| Q2 2026 | -$3.7M | +$2.4M |
| Q1 2026 | -$3M | +$3.7M |
| Q4 2025 | -$4.1M | -$3.4M |
| Q3 2025 | -$4.9M | +$1.6M |
| Q2 2025 | -$6.1M | +$1.4M |
| Q1 2025 | -$6.6M | -$1.4M |
| Q4 2024 | -$642.7K | +$1.4M |
FOCL has burned cash in most quarters: −$15M over the past year, against −$18M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over FOCL on cash generation, producing positive trailing cash flow while its opponent burns cash.
FOCL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +14% | +5.1M shares |
| 1 year | +14% | +5.2M shares |
| 3 years | +15% | +5.6M shares |
| 5 years | +32% | +10.4M shares |
| Available history | +58% | +15.6M shares |
FOCL has 43M diluted shares, up 14% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over FOCL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
FOCL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | -12.2x | Net Cash |
| Q2 2022 | -13.3x | Net Cash |
| Q1 2022 | -85.7x | Net Cash |
| Q4 2021 | -148.8x | Net Cash |
| Q3 2021 | -49.2x | Net Cash |
| Q2 2021 | -27.7x | Net Cash |
FOCL has more cash than debt.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
FOCL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 4.9 | Oversold |
FOCL's weekly RSI is 38 (neutral) and its Stochastic is 5 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
FOCL PE vs Healthcare Sector
| Metric | FOCL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
FOCL has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
FOCL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.03 | 15% below |
| 20 week MA | $4.62 | 26% below |
| 50 week MA | $4.20 | 19% below |
| 100 week MA | $3.12 | 9.3% above |
| 200 week MA | $4.98 | 32% below |
FOCL's trend is mixed: it's above one of its five weekly moving averages, and 32% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over FOCL on trend strength, trading above more of its moving averages.
FOCL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.40 | $5.08 | +15% |
| 2021 | $5.08 | $5.65 | +11% |
| 2022 | $5.65 | $10.5 | +86% |
| 2023 | $10.5 | $5.28 | -50% |
| 2024 | $5.28 | $2.17 | -59% |
| 2025 | $2.17 | $3.40 | +57% |
| 2026 YTD | $3.40 | $3.41 | +0.3% |
FOCL has finished higher in four of the last six years, two of them by more than 50%. It's roughly flat so far in 2026.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over FOCL on returns for 2026, with the stronger performance.